What role for AID: Mutator, or assembler of the immunoglobulin mutasome?

Nature Immunology

Volumn 4, Issue 7, 2003, Pages 631-638

  Reynaud, Claude Agnès ^a   Aoufouchi, Said ^a   Faili, Ahmad ^a   Weill, Jean Claude ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTIDINE DEAMINASE; DNA; DNA POLYMERASE; EXONUCLEASE; IMMUNOGLOBULIN; RNA;

B LYMPHOCYTE; DEAMINATION; DNA REPAIR; ENZYME ACTIVATION; GENE CONVERSION; GENE LOCUS; GENE MUTATION; GENE SWITCHING; GENETIC RECOMBINATION; GENETIC VARIABILITY; HUMAN; IMMUNE SYSTEM; IMMUNOGLOBULIN GENE; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SOMATIC HYPERMUTATION;

ANIMALS; CYTIDINE DEAMINASE; DNA DAMAGE; DNA-DIRECTED DNA POLYMERASE; GENES, IMMUNOGLOBULIN; HUMANS; RNA EDITING; SOMATIC HYPERMUTATION, IMMUNOGLOBULIN; TRANSCRIPTION, GENETIC;

EID: 0037625159     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/ni0703-631     Document Type: Review

References (107)

1. Hesslein, D.G. & Schatz, D.G. Factors and forces controlling V(D)J recombination. Adv. Immunol. 78, 169-232 (2001).
2. Berek, C. & Milstein, C. The dynamic nature of the antibody repertoire. Immunol. Rev. 105, 5-26 (1988).
3. Stavnezer, J. Antibody class switching. Adv. Immunol. 61, 79-146 (1996).
4. Weill, J.-C. & Reynaud, C.-A. Rearrangement/hypermutation/gene conversion: when, where and why? Immunol. Today 17, 92-97 (1996).
5. Muramatsu, M. et al. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102, 553-563 (2000).
6. Revy, P. et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 102, 565-575 (2000).
7. Harris, R.S., Sale, J.E., Petersen-Mahrt, S.K. & Neuberger, M.S. AID is essential for immunoglobulin V gene conversion in a cultured B cell line. Curr. Biol. 12, 435-438 (2002).
8. Arakawa, H., Hauschild, J. & Buerstedde, J.M. Requirement of the activation-induced deaminase (AID) gene for immunoglobulin gene conversion. Science 295, 1301-1306 (2002).
9. Yoshikawa, K. et al. AID enzyme-induced hypermutation in an actively transcribed gene in fibroblasts. Science 296, 2033-2036 (2002).
10. Okazaki, I.M., Kinoshita, K., Muramatsu, M., Yoshikawa, K. & Honjo, T. The AID enzyme induces class switch recombination in fibroblasts. Nature 416, 340-345 (2002).
11. Gearhart, P. & Wood, R.D. Emerging links between hypermutation of antibody genes and DNA polymerases. Nat. Rev. Immunol. 1, 187-192 (2001).
12. Martin, A. & Scharff, M.D. AID and mismatch repair in antibody diversification. Nat. Rev. Immunol. 2, 605-614 (2002).
13. Papavasiliou, F.N. & Schatz, D.G. Somatic hypermutation of immunoglobulin genes: merging mechanisms for genetic diversity. Cell 109, S35-44 (2002).
14. Honjo, T., Kinoshita, K. & Muramatsu, M. Molecular mechanism of class switch recombination: linkage with somatic hypermutation. Annu. Rev. Immunol. 20, 165-196 (2002).
15. Manis, J.P., Tian, M. & Alt, F.W. Mechanism and control of class-switch recombination. Trends Immunol. 23, 31-39 (2002).
16. Weill, J.-C. et al. Ig gene hypermutation: a mechanism is due. Adv. Immunol. 80, 183-202 (2002).
17. Muramatsu, M. et al. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J. Biol. Chem. 274, 18470-18476 (1999).
18. Anant, S. & Davidson, N.O. Molecular mechanisms of apolipoprotein B mRNA editing. Curr. Opin. Lipidol. 12, 159-165 (2001).
19. Wilson, M. et al. What limits affinity maturation of antibodies in Xenopus - the rate of somatic mutation or the ability to select mutants? EMBO J. 11, 4337-4719 (1992).
20. Bachl, J. & Wabl, M. An immunoglobulin mutator that targets G.C base pairs. Proc. Natl. Acad. Sci. USA 93, 851-855 (1996).
21. Rada, C., Ehrenstein, M.R., Neuberger, M.S. & Milstein, C. Hot-spot focusing of somatic hypermutation in MSH2-deficient mice suggests two stages of mutational targeting. Immunity 9, 135-141 (1998).
22. Frey, S. et al. Mismatch repair deficiency interferes with the accumulation of mutations in chronically stimulated B cells and not with the hypermutation process. Immunity 9, 127-134 (1998).
23. Phung, Q.H. et al. Increased hypermutation at G and C nucleotides in immunoglobulin variable genes from mice deficient in the MSH2 mismatch repair protein. J. Exp. Med. 187, 1745-1751 (1998).
24. Jacobs, H. et al. Hypermutation of immunoglobulin genes in memory B cells of DNA repair-deficient mice. J. Exp. Med. 187, 1735-1743 (1998).
25. Denepoux, S. et al. Induction of somatic mutation in a human B cell line in vitro. Immunity 6, 35-46 (1997).
26. Sale, J.E. & Neuberger, M.S. TdT-accessible breaks are scattered over the immunoglobulin V domain in a constitutively hypermutating B cell line. Immunity 9, 859-869 (1998).
27. + B cell line in vitro: definition of the requirements and modalities of hypermutation. J. Immunol. 162, 3437-3447 (1999).
28. Martin, A. et al. Activation-induced cytidine deaminase turns on somatic hypermutation in hybridomas. Nature 415, 802-806 (2002).
29. Di Noia, J. & Neuberger, M.S. Altering the pathway of immunoglobulin hypermutation by inhibiting uracil-DNA glycosylase. Nature 419, 43-48 (2002).
30. Rada, C. et al. Immunoglobulin isotype switching is inhibited and somatic hypermutation perturbed in UNG-deficient mice. Curr. Biol. 12, 1748-1755 (2002).
31. Petersen-Mahrt, S.K., Harris, R.S. & Neuberger, M.S. AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification. Nature 418, 99-103 (2002).
32. Harris, R.S., Petersen-Mahrt, S.K. & Neuberger, M.S. RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators. Mol. Cell 10, 1247-1253 (2002).
33. Doi, T., Kinoshita, K., Ikegawa, M., Muramatsu, M. & Honjo, T. De novo protein synthesis is required for the activation-induced cytidine deaminase function in class-switch recombination. Proc. Natl. Acad. Sci. USA. 100, 2634-2638 (2003).
34. Krokar, H.E., Drablos, F. & Slupphaug, G. Uracil in DNA - occurrence, consequences and repair. Oncogene 21, 8935-8948 (2002).
35. Tissier, A., McDonald, J.P., Frank, E.G. & Woodgate, R. Pol ι, a remarkably error-prone human DNA polymerase. Genes Dev. 14, 1642-1650 (2000).
36. Matsuda, T. et al. Low fidelity DNA synthesis by human DNA polymerase-η. Nature 404, 1011-1013 (2000).
37. Kunkel, T.A., Pavlov, Y.I. & Bebenek, K. Functions of human DNA polymerases η, κ and ι suggested by their properties, including fidelity with undamaged DNA templates. DNA Repair 2, 135-149 (2003).
38. Johnson, R.E., Washington, M.T., Haracska, L., Prakash, S. & Prakash, L. Eukaryotic polymerases ? and ζ act sequentially to bypass DNA lesions. Nature 406, 1015-1019 (2000).
39. Bemark, M., Khamlichi, A.A., Davies, S.L. & Neuberger, M.S. Disruption of mouse polymerase ζ (Rev3) leads to embryonic lethality and impairs blastocyst development in vitro. Curr. Biol. 10, 1213-1216 (2000).
40. Wittschieben, J. et al. Disruption of the developmentally regulated Rev3l gene causes embryonic lethality. Curr. Biol. 10, 1217-1220 (2000).
41. Esposito, G. et al. Disruption of the Rev3l-encoded catalytic subunit of polymerase ζ in mice results in early embryonic lethality. Curr. Biol. 10, 1221-1224 (2000).
42. Morrison, A. et al. REV3, a Saccharomyces cerevisiae gene whose function is required for induced mutagenesis, is predicted to encode a nonessential DNA polymerase. J. Bacteriol. 171, 5659-5667 (1989).
43. Masutani, C. et al. The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase η. Nature 399, 700-704 (1999).
44. Johnson, R.E., Kondratick, C.M., Prakash, S. & Prakash, L. hRAD30 mutations in the variant form of xeroderma pigmentosum. Science 285, 263-265 (1999).
45. Zeng, X. et al. DNA polymerase η is an A-T mutator in somatic hypermutation of immunoglobulin variable genes. Nat. Immunol. 2, 537-541 (2001).
46. Yavuz, S., Yavuz, A.S., Kraemer, K.H. & Lipsky, P.E. The role of polymerase η in somatic hypermurtation determined by analysis of mutations in a patient with xeroderma pigmentosum variant. J. Immunol. 169, 3825-3830 (2002).
47. Faili, A. et al. AID-dependent somatic hypermutation occurs as a DNA single strand event in the BL2 cell line. Nat. Immunol. 3, 815-821 (2002).
48. Greagg, M.A. et al. A read-ahead function in archaeal DNA polymerases detects promutagenic template-strand uracil. Proc. Natl. Acad. Sci. USA 96, 9045-9050 (1999).
49. Faili, A. et al. Induction of somatic hypermutation in immunoglobulin genes is dependent on DNA polymerase ι. Nature 419, 944-947 (2002).
50. Kannouche, P. et al. Localization of DNA polymerases Η and ι to the replication machinery is tightly co-ordinated in human cells. EMBO J. 21, 6246-6256 (2002).
51. Rogozin, I.B. & Kolchanov, N.A. Somatic hypermutagenesis in immunoglobulin genes. II. Influence of neighbouring base sequences on mutagenesis. Biochim. Biophys. Acta 1171, 11-18 (1992).
52. Rogozin, I.B., Pavlov, Y.I., Bebenek, K., Matsuda, T. & Kunkel, T.A. Somatic mutation hotspots correlate with DNA polymerase η error spectrum. Nat. Immunol. 2, 530-536 (2001).
53. Pavlov, Y.I. et al. Correlation of somatic hypermutation specificity and A-T base pair substitution errors by DNA polymerase η during copying of a mouse immunoglobulin κ light chain transgene. Proc. Natl. Acad. Sci. USA 99, 9954-9959 (2002).
54. Zan, H. et al. The translesion DNA polymerase ζ plays a major role in Ig and Bcl-6 somatic hypermutation. Immunity 14, 643-653 (2001).
55. Diaz, M., Verkoczy, F.K., Flajnik, M.F. & Klinman, N.R. Decreased frequency of somatic hypermutation and impaired affinity maturation but intact germinal center formation in mice expressing antisense RNA to DNA polymerase ζ. J. Immunol. 167, 327-335 (2001).
56. Reynaud, C.A. et al. Mismatch repair and immunoglobulin gene hypermutation: did we learn something? Immunol. Today 20, 522-527 (1999).
57. Alabyev, B. & Manser, T. Bcl-2 rescues the germinal center response but does not alter the V gene somatic hypermutation spectrum in MSH2-deficient mice. J. Immunol. 169, 3819-3824 (2002).
58. Wiesendanger, M., Kneitz, B., Edelmann, W. & Scharff, M.D. Somatic hypermutation in MutS homologue (MSH)3-, MSH6-, and MSH3/MSH6-deficient mice reveals a role for the MSH2-MSH6 heterodimer in modulating the base substitution pattern. J. Exp. Med. 191, 579-584 (2000).
59. Phung, Q.H., Winter, D.B., Alrefai, R. & Gearhart, P.J. Hypermutation in Ig V genes from mice deficient in the MLH1 mismatch repair protein. J. Immunol. 162, 3121-3124 (1999).
60. Winter, D.B. et al. Altered spectra of hypermutation in antibodies from mice deficient for the DNA mismatch repair protein PMS2. Proc. Natl. Acad. Sci. USA 95, 6953-6958 (1998).
61. Ehrenstein, M.R., Rada, C., Jones, A.M., Milstein, C. & Neuberger, M.S. Switch junction sequences in PMS2-deficient mice reveal a microhomology-mediated mechanism of Ig class switch recombination. Proc. Natl. Acad. Sci. USA 98, 14553-14558 (2002).
62. Wang, H., Lawrence, C.W., Li, G.M. & Hays, J.B. Specific binding of human MSH2-MSH6 mismatch-repair protein heterodimers to DNA incorporating thymine- or uracil-containing UV light photoproducts opposite mismatched bases. J. Biol. Chem. 274, 16894-16900 (1999).
63. Edelmann, W. et al. Mutation in the mismatch repair gene Msh6 causes cancer susceptibility. Cell 91, 467-477 (1997).
64. Schlissel, M., Constantinescu, A., Morrow, T., Baxter, M. & Peng, A. Double-strand signal sequence breaks in V(D)J recombination are blunt, 5′-phosphorylated, RAG-dependent, and cell cycle regulated. Genes Dev. 7, 2520-2532 (1993).
65. Lin, W.C. & Desiderio, S. Cell cycle regulation of V(D)J recombination-activating protein RAG-2. Proc. Natl. Acad. Sci. USA 91, 2733-2737 (1994).
66. Petersen S. et al. AID is required to initiate Nbs1/γ-H2AX focus formation and mutations at sites of class switching. Nature 414, 660-665 (2001).
67. Papavasiliou, F.N. & Schatz, D.G. Cell-cycle-regulated DNA double-stranded breaks in somatic hypermutation of immunoglobulin genes. Nature 408, 216-221 (2000).
68. Bross, L. et al. DNA double-strand breaks in immunoglobulin genes undergoing somatic hypermutation. Immunity 13, 589-597 (2000).
69. Bross, L., Muramatsu, M., Kinoshita, K., Honjo, T. & Jacobs, H. DNA double-strand breaks: prior to but not sufficient in targeting hypermutation. J. Exp. Med. 195, 1187-1192 (2002).
70. Papavasiliou, F.N. & Schatz, D.G. The activation-induced deaminase functions in a postcleavage step of the somatic hypermutation process. J. Exp. Med. 195, 1193-1198 (2002).
71. Kong, Q. & Maizels, N. DNA breaks in hypermutating immunoglobulin genes: evidence for a break-and-repair pathway of somatic hypermutation. Genetics 158, 369-378 (2001).
72. Lebecque, S.G. & Gearhart, P.J. Boundaries of somatic mutation in rearranged immunoglobulin genes: 5′ boundary is near the promoter, and 3′ boundary is approximately 1 kb from V(D)J gene. J. Exp. Med. 172, 1717-1727 (1990).
73. Betz, A.G. et al. Elements regulating somatic hypermutation of an immunoglobulin gene: critical role for the intron enhancer/matrix attachment region. Cell 77, 239-248 (1994).
74. Peters, A. & Storb, U. Somatic hypermutation of immunoglobulin genes is linked to transcription initiation. Immunity 4, 57-65 (1996).
75. Goyenechea, B. et al. Cells strongly expressing Igκ transgenes show clonal recruitment of hypermutation: a role for both MAR and the enhancers. EMBO J. 16, 3987-3994 (1997).
76. Fukita, Y., Jacobs, H. & Rajewsky, K. Somatic hypermutation in the heavy-chain locus correlates with transcription. Immunity 9, 105-114 (1998).
77. Bachl, J., Carlson, C., Gray-Schopfer, V., Dessing, M. & Olsson, C. Increased transcription levels induce higher mutation rates in a hypermutating cell line. J. Immunol. 166, 5051-5057 (2001).
78. Bransteitter, R., Pham, P., Scharff, M.D. & Goodman, M.F. Activation-induced cytidine deaminase deaminates deoxycytidine on single-stranded DNA but requires the action of RNase. Proc. Natl. Acad. Sci. USA 100, 4102-4107 (2003).
79. Chaudhuri, J. et al. Transcription-targeted DNA deamination by the AID antibody diversification enzyme. Nature 422, 726-730 (2003).
80. Ramiro, A.R., Stavropoulos, P., Jankovic, M. & Nussenzweig, M.C. Transcription enhances AID-mediated cytidine deamination by exposing single-stranded DNA on the nontemplate strand. Nat Immunol. 4, 452-456 (2003).
81. HJ rearrangements. Immunol. Reviews 162, 161-171 (1998).
82. Milstein, C., Neuberger, M.S. & Staden, R. Both DNA strands of antibody genes are hypermutation targets. Proc. Natl. Acad. Sci. USA 95, 8791-8794 (1998).
83. H genes suggest different GC and AT mutators. J. Immunol. 162, 6596-6601 (1999).
84. Rada, C., Jarvis, J.M. & Milstein, C. AID-GFP chimeric protein increases hypermutation of Ig genes with no evidence of nuclear localization. Proc. Natl. Acad. Sci. USA 99, 7003-7008 (2002).
85. Martin, A. & Scharff, M.D. Somatic hypermutation of the AID transgene in B and non-B cells. Proc. Natl. Acad. Sci. USA 99, 12304-12308 (2002).
86. Sale, J.E., Calandrini, D.M., Takata, M., Takeda, S. & Neuberger, M.S. Ablation of XRCC2/3 transforms immunoglobulin V-gene conversion into somatic hypermutation. Nature 412, 921-926 (2001).
87. Takata, M. et al. Chromosome instability and defective recombinational repair in knock-out mutants of the five Rad51 paralogs. Mol. Cell. Biol. 21, 2858-2866 (2001).
88. Ehrenstein, M.R. & Neuberger, M.S. Deficiency in Msh2 affects the efficiency and local sequence specificity of immunoglobulin class-switch recombination: parallels with somatic hypermutation. EMBO J. 18, 3484-3490 (1999).
89. Schrader, C.E., Edelmann, W., Kucherlapati, R. & Stavnezer, J. Reduced isotype switching in splenic B cells from mice deficient in mismatch repair enzymes. J. Exp. Med. 190, 323-330 (1999).
90. Schrader, C.E., Vardo, J. & Stavnezer, J. Role for mismatch repair proteins Msh2, Mlh1, and Pms2 in immunoglobulin class switching shown by sequence analysis of recombination junctions. J. Exp. Med. 195, 367-373 (2002).
91. 2b transcripts: evidence for directed heavy chain class switching. Cell 53, 177-184 (1988).
92. Stavnezer, J. et al. Immunoglobulin heavy-chain switching may be directed by prior induction of transcripts from constant-region genes. Proc. Natl. Acad. Sci. USA 85, 7704-7708 (1988).
93. Hein, K. et al. Processing of switch transcripts is required for targeting of antibody class-switch recombination. J. Exp. Med. 188, 2369-2374 (1998).
94. Reaban, M.E. & Griffin, J.A. Induction of RNA-stabilized DNA conformers by transcription of an immunoglobulin switch region. Nature 348, 342-344 (1990).
95. Daniels, G.A. & Lieber, M.R. RNA:DNA complex formation upon transcription of immunoglobulin switch regions: implications for the mechanism and regulation of class switch recombination. Nucleic Acids Res. 23, 5006-5011 (1995).
96. Shinkura, R. et al. The influence of transcriptional orientation on endogenous switch region function. Nat. Immunol. 4, 435-441 (2003).
97. Yu, K., Chedin, F., Hsieh, C.L., Wilson, T.E. & Lieber, M.R. R-loops at immunoglobulin class switch regions in the chromosomes of stimulated B cells. Nat. Immunol. 4, 442-451 (2003).
98. Kuppers, R. & Dalla-Favera, R. Mechanisms of chromosomal translocations in B-cell lymphomas. Oncogene 20, 5580-5594 (2001).
99. Dunnick, W., Hertz, G.Z., Scappino, L. & Gritzmacher, C. DNA sequences at immunoglobulin switch region recombination sites. Nucleic Acids Res. 21, 365-372 (1993).
100. Nagaoka, H., Muramatsu, M., Yamamura, N., Kinoshita, K. & Honjo, T. Activation-induced deaminase (AID)-directed hypermutation in the immunoglobulin S region: implication of AID involvement in a common step of class switch recombination and somatic hypermutation. J. Exp. Med. 195, 529-534 (2002).
101. Oppezzo, P. et al. Chronic lymphocytic leukemia B cells expressing AID display a dissociation between class switch recombination and somatic hypermutation. Blood 101, 4029-4032 (2003).
102. H, but is involved in the introduction of mutations in switch μ region. J. Immunol. 170, 3707-3716 (2003).
103. Shen, H.M., Peters, A., Baron, B., Zhu, X. & Storb, U. Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes. Science 280, 1750-1752 (1998).
104. Pasqualucci, L. et al. BCL-6 mutations in normal germinal-center B cells: evidence of somatic hypermutation acting outside Ig loci. Proc. Natl. Acad. Sci. USA 95, 11816-11821 (1998).
105. Muschen, M. et al. Somatic mutation of the CD95 gene in human B cells as a side-effect of the germinal-center reaction. J. Exp. Med. 192, 1833-1840 (2000).
106. Pasqualucci, L. et al. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 412, 341-346 (2001).
107. McCarthy, H. et al. High expression of activation-induced cytidine deaminase (AID) and splice variants is a distinctive feature of poor prognosis chronic lymphocytic FFFleukemia. Blood 101, 4903-4908 13 February 2003 (10.1182/blood-2002-09-2906).